Chris Beat Cancer: Heal With Nutrition & Natural Therapies How Julie Stevens used data analysis to survive stage IV colon cancer against the odds
Sep 9, 2026
Julie Stevens, an industrial-organizational psychologist, data analyst, author, and stage IV colon cancer survivor, shares her radical remission journey. She explores genomic testing, biomarkers, AI-assisted treatment research, and advanced cancer monitoring. Julie also discusses bringing joy into infusions, tracking survivor patterns, and building smarter, whole-body approaches to cancer care.
AI Snips
Chapters
Books
Transcript
Episode notes
Measure Treatment Before Waiting For Scans
- Ask how treatment effectiveness will be measured before starting therapy instead of waiting months for a scan.
- Julie used NGS testing, circulating tumor DNA, and CA 19-9 because CEA was not her useful marker.
Blood Data Exposed Julie’s Failing Chemotherapy
- Julie’s genomic results suggested platinum chemotherapy might fail against her KRAS G13D tumor, but her oncologist initially dismissed her.
- Rising blood markers and PET results eventually confirmed her concern, prompting a switch to immunotherapy.
Immunotherapy Worked Within A Broader Healing Strategy
- Julie’s near-complete response followed one Keytruda infusion, but she attributes the outcome to preparation beyond the drug.
- She connected nutrition, microbiome support, weight loss, exercise, and trauma work with her immune system’s response.
